.png)
.png)
.jpg "Rick A. Elion, MD photo")
Clinical Professor of Medicine George Washington University School of Medicine
Trio Health
Disclosure(s): Gilead Sciences: Advisor/Consultant; Trio Health: Employee; ViiV: Advisor/Consultant
Dr Richard Elion has been active in HIV care and research since 1984 and has done some of the foundational research to establish the approval and use of many of the currently used HIV medications. He is a board certified family doctor and did his training at Temple University School of Medicine, and family medicine residency at Duke University School of Medicine. Dr Elion began his HIV career in Brooklyn New York in community health and working at the Dept of Health in NYC. He went on to work at Columbia University School of Medicine and participated widely in community based HIV research. He later moved to Washington DC and was the research director at Whitman Walker Health for 8 years and supervised the establishment of an Aids Clinical Trial site in conjunction with Johns Hopkins University while there and did early work on HIV prevention and on community projects demonstrating the benefits of biomedical prevention and HIV. He later moved to Washington Health Institute, where he is currently the Director of Clinical Research and also works at the DC dept of heatlh in the sexual health program. Dr. Elion also combines an integrated person centered approach to all his care and educational efforts having completed the course work in a masters in counselling from the University of Santa Monica. He has been the Scientific Director of Trio Health HIV program and a vice president of strategic initiatives at Trio Health since 2017.